⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BIIB

Biogen Inc.

Healthcare · Drug Manufacturers - General

250.69USD

-3.1500 (-1.24%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BIIB.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 250.69
P/E27.0
Dvd Ind Yld0.0%
P/B1.99
P/S3.7
Curr EV/T12M EBITDA15.3
Mkt Cap (USD)37.0B
Curr EV (USD)44.1B
2)

Per Share Data

EPS T12M9.32
DPS—
Bk Val Per Sh127.61
Rev/Sh66.96
Cash/Sh8.70
Curr Shares Out147.8M
FCF/Sh16.33
3)

Cash Flow Analysis

P/CF14.3
Curr P/FCF15.3
CF/NI1.9
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales26.1%
Eff Interest Rate5.1%
4)

Growth Potential

Dil EPS 1Y Gr-21.4%
Cap 1Y Gr6.7%
BPS 1Y Gr8.3%
R&D To Sales12.7%
Retention Rate100.0%
Rev 1Y Gr2.2%
FCF 1Y Gr-24.7%
Assets 1Y Gr5.0%
5)

Profitability

EBITDA2.9B
EBIT2.5B
Operating Margin24.9%
Pretax Margin16.3%
Net Margin13.8%
ROA4.8%
ROE7.7%
ROC8.4%
Asset Turnover0.35
6)

Structure

Current Ratio3.06
Quick Ratio0.94
Debt/Assets21.3%
Debt/Com Eq33.7%
Net Debt/EBITDA1.01
Tot Debt/Capital25.2%
Gross Margin75.5%
EBIT/Int Exp9.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.